306250
Association between disability, sleep and chronic conditions
Methods: We analyzed data from 20 states that used the sleep module in the 2009-2010 Behavioral Risk Factor Surveillance System to determine hours of sleep and chronic disease by disability status. We performed logistic regression to determine moderating effects of amount of sleep (categorized as ≤5, 6, 7, 8 and 9+ hours in a 24 hour period) on the association between disability and 5 chronic conditions (stroke, hypertension, obesity, diabetes and high cholesterol).
Results: The associations between disability and stroke (aOR: 4.1, 95% CI: 3.2, 5.4; 6 hours of sleep) and disability and hypertension (aOR: 2.6, 95% CI: 1.9, 3.4; ≤5 hours of sleep) were both strongest among those reporting fewer hours of sleep. The association between disability and obesity was weakest among those reporting 9+ hours of sleep (aOR: 1.61, 95% CI: 1.34, 1.94). The association between disability and diabetes was similar across all levels of sleep (aOR range: 1.93 to 2.33). Finally, the association between disability and high cholesterol was weakest among those reporting 7 hours of sleep (aOR: 1.33, 95% CI: 1.12, 1.57).
Conclusion: The strength of the association between disability and chronic conditions varied by hours of sleep. Programs promoting the health of people with disabilities may benefit from promoting the importance of sleep.
Learning Areas:
EpidemiologyLearning Objectives:
Describe the differences in prevalence of amount of sleep by disability status.
Explain how the association between disability and chronic conditions may vary by amount of sleep.
Keyword(s): Epidemiology, Disabilities
Qualified on the content I am responsible for because: I have been a health scientist working in the area of disability research and epidemiology for the past 6 years. I have been involved in several projects utilizing different analytic techniques to examine health disparities experienced by people with disabilities.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.